KCTech Balance Sheet Health
Financial Health criteria checks 6/6
KCTech has a total shareholder equity of ₩452.6B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩500.0B and ₩47.3B respectively. KCTech's EBIT is ₩32.7B making its interest coverage ratio -3.6. It has cash and short-term investments of ₩199.4B.
Key information
0%
Debt to equity ratio
₩0
Debt
Interest coverage ratio | -3.6x |
Cash | ₩199.45b |
Equity | ₩452.61b |
Total liabilities | ₩47.34b |
Total assets | ₩499.95b |
Recent financial health updates
No updates
Recent updates
At ₩34,100, Is KCTech Co., Ltd. (KRX:281820) Worth Looking At Closely?
Apr 23KCTech (KRX:281820) Could Be Struggling To Allocate Capital
Apr 05Subdued Growth No Barrier To KCTech Co., Ltd. (KRX:281820) With Shares Advancing 31%
Feb 29Should You Be Excited About KCTech Co., Ltd.'s (KRX:281820) 13% Return On Equity?
Mar 16What Is The Ownership Structure Like For KCTech Co., Ltd. (KRX:281820)?
Feb 26Will KCTech (KRX:281820) Multiply In Value Going Forward?
Feb 08A Look At The Intrinsic Value Of KCTech Co., Ltd. (KRX:281820)
Jan 22Introducing KCTech (KRX:281820), A Stock That Climbed 52% In The Last Three Years
Jan 07Are KCTech's (KRX:281820) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 23Should You Be Excited About KCTech Co., Ltd.'s (KRX:281820) 13% Return On Equity?
Dec 08Is KCTech Co., Ltd.'s (KRX:281820) Shareholder Ownership Skewed Towards Insiders?
Nov 19Financial Position Analysis
Short Term Liabilities: A281820's short term assets (₩372.7B) exceed its short term liabilities (₩42.1B).
Long Term Liabilities: A281820's short term assets (₩372.7B) exceed its long term liabilities (₩5.2B).
Debt to Equity History and Analysis
Debt Level: A281820 is debt free.
Reducing Debt: A281820 has not had any debt for past 5 years.
Debt Coverage: A281820 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: A281820 has no debt, therefore coverage of interest payments is not a concern.